(19)
(11) EP 1 718 298 A2

(12)

(88) Date of publication A3:
27.04.2006

(43) Date of publication:
08.11.2006 Bulletin 2006/45

(21) Application number: 05713450.4

(22) Date of filing: 14.02.2005
(51) International Patent Classification (IPC): 
A61K 31/435(2006.01)
C07D 211/06(2006.01)
A61K 31/445(2006.01)
(86) International application number:
PCT/US2005/004529
(87) International publication number:
WO 2005/079337 (01.09.2005 Gazette 2005/35)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR LV MK YU

(30) Priority: 17.02.2004 US 545109 P

(71) Applicant: Merck & Co., Inc.
Rahway, NJ 07065-0907 (US)

(72) Inventors:
  • CONDON, Shannon
    Rahway, New Jersey 07065-0907 (US)
  • DEVINE, Paul
    Rahway, New Jersey 07065-0907 (US)
  • GAUTHIER, DONALD, R., Jr.
    Rahway, New Jersey 07065-0907 (US)
  • LIMANTO, John
    Rahway, New Jersey 07065-0907 (US)
  • SZUMIGALA, Ronald, H., Jr.
    Rahway, New Jersey 07065-0907 (US)

(74) Representative: Buchan, Gavin MacNicol 
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)

   


(54) PROCESS FOR MAKING EP4 AGONISTS AND INTERMEDIATES THEREOF